BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 11015555)

  • 1. Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice.
    Davisson RL; Ding Y; Stec DE; Catterall JF; Sigmund CD
    Physiol Genomics; 1999 Jul; 1(1):3-9. PubMed ID: 11015555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
    Sachetelli S; Liu Q; Zhang SL; Liu F; Hsieh TJ; Brezniceanu ML; Guo DF; Filep JG; Ingelfinger JR; Sigmund CD; Hamet P; Chan JS
    Kidney Int; 2006 Mar; 69(6):1016-23. PubMed ID: 16528251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter.
    Morimoto S; Cassell MD; Beltz TG; Johnson AK; Davisson RL; Sigmund CD
    Circ Res; 2001 Aug; 89(4):365-72. PubMed ID: 11509454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Pressure Lowering and Safety Improvements With Liver Angiotensinogen Inhibition in Models of Hypertension and Kidney Injury.
    Mullick AE; Yeh ST; Graham MJ; Engelhardt JA; Prakash TP; Crooke RM
    Hypertension; 2017 Sep; 70(3):566-576. PubMed ID: 28716988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.
    Goto M; Hoxha N; Osman R; Dell KM
    Pediatr Nephrol; 2010 Dec; 25(12):2449-57. PubMed ID: 20798958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
    Lo CS; Liu F; Shi Y; Maachi H; Chenier I; Godin N; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Am J Physiol Renal Physiol; 2012 Apr; 302(7):F840-52. PubMed ID: 22205225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II increases adipose angiotensinogen expression.
    Lu H; Boustany-Kari CM; Daugherty A; Cassis LA
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1280-7. PubMed ID: 17213477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of renin-angiotensin system blockade on the expression of the angiotensinogen gene and induction of hypertrophy in rat kidney proximal tubular cells.
    Zhang SL; To C; Chen X; Filep JG; Tang SS; Ingelfinger JR; Carrière S; Chan JS
    Exp Nephrol; 2001; 9(2):109-17. PubMed ID: 11150859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The brain renin-angiotensin system in transgenic mice carrying a highly regulated human renin transgene.
    Morimoto S; Cassell MD; Sigmund CD
    Circ Res; 2002 Jan; 90(1):80-6. PubMed ID: 11786522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan prevents the elevation of blood pressure in adipose-PRR deficient female mice while elevated circulating sPRR activates the renin-angiotensin system.
    Gatineau E; Cohn DM; Poglitsch M; Loria AS; Gong M; Yiannikouris F
    Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H506-H515. PubMed ID: 30550352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of intrarenal renin-agiotensin system contributes to renal damage in high-salt induced hypertension rats.
    Wu H; Liang Y; Zheng Y; Bai Q; Zhuang Z; A L; Zheng D; Wang Y
    Kidney Blood Press Res; 2014; 39(6):526-35. PubMed ID: 25531334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell autonomous angiotensin II signaling controls the pleiotropic functions of oncogenic K-Ras.
    Volonte D; Sedorovitz M; Cespedes VE; Beecher ML; Galbiati F
    J Biol Chem; 2021; 296():100242. PubMed ID: 33380422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
    Loghman-Adham M; Soto CE; Inagami T; Cassis L
    Am J Physiol Renal Physiol; 2004 Oct; 287(4):F775-88. PubMed ID: 15187005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive hypertension and end-organ damage in a transgenic mouse line carrying the rat angiotensinogen gene.
    Xu P; Wang Y; Sterner-Kock A; Bader M; Schultheiss HP; Walther T
    J Cardiovasc Pharmacol; 2009 Jan; 53(1):38-43. PubMed ID: 19129738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice.
    Yiannikouris F; Wang Y; Shoemaker R; Larian N; Thompson J; English VL; Charnigo R; Su W; Gong M; Cassis LA
    Hypertension; 2015 Oct; 66(4):836-42. PubMed ID: 26303292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.
    Ohashi N; Yamamoto T; Huang Y; Misaki T; Fukasawa H; Suzuki H; Togawa A; Suzuki S; Fujigaki Y; Nakagawa T; Nakamura Y; Suzuki F; Kitagawa M; Hishida A
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1512-8. PubMed ID: 18784264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A haplotype of human angiotensinogen gene containing -217A increases blood pressure in transgenic mice compared with -217G.
    Jain S; Vinukonda G; Fiering SN; Kumar A
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1849-57. PubMed ID: 18945948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat.
    Zimpelmann J; Kumar D; Levine DZ; Wehbi G; Imig JD; Navar LG; Burns KD
    Kidney Int; 2000 Dec; 58(6):2320-30. PubMed ID: 11115066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice.
    Kobori H; Ozawa Y; Satou R; Katsurada A; Miyata K; Ohashi N; Hase N; Suzaki Y; Sigmund CD; Navar LG
    Am J Physiol Renal Physiol; 2007 Sep; 293(3):F938-45. PubMed ID: 17634399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to genetic manipulations of liver angiotensinogen in the physiological range.
    Gociman B; Rohrwasser A; Hillas E; Cheng T; Hunter G; Hunter J; Lott P; Monson S; Ying J; Lalouel JM
    J Hum Genet; 2008; 53(9):775-788. PubMed ID: 18600297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.